Protein biomarker discovery and validation: the long and uncertain path to clinical utility

Rifai, Nader, Gillette, Michael A, Carr, Steven A·2006·Nature Biotechnology
DOI 10.1038/nbt1235

Cited by (1,000)

Items 101–200 of 1,000

  1. Integrated Pipeline for Mass Spectrometry-Based Discovery and Confirmation of Biomarkers Demonstrated in a Mouse Model of Breast Cancer
    Jeffrey R. Whiteaker, Heidi Zhang, Lei Zhao, Pei Wang, Karen S. Kelly‐Spratt, Richard G. Ivey, Brian Piening, Li-Chia Feng, Erik Kasarda, Kay E. Gurley et al. · 2007 · Journal of Proteome Research
  2. An introduction to artificial neural networks in bioinformatics--application to complex microarray and mass spectrometry datasets in cancer studies
    Lee Lancashire, Christophe Lemetre, Graham Ball · 2008 · Briefings in Bioinformatics
  3. Missing data in multi-omics integration: Recent advances through artificial intelligence
    Flores, Javier E., Claborne, Daniel M., Weller, Zachary D., Webb-Robertson, Bobbie-Jo M., Waters, Katrina M., Bramer, Lisa M. · 2023 · Frontiers in Artificial Intelligence
  4. Waste, Leaks, and Failures in the Biomarker Pipeline
    John P. A. Ioannidis, Patrick M. Bossuyt · 2017 · Clinical Chemistry
  5. Peptide Labeling with Isobaric Tags Yields Higher Identification Rates Using iTRAQ 4-Plex Compared to TMT 6-Plex and iTRAQ 8-Plex on LTQ Orbitrap
    Peter Pichler, Thomas Köcher, Johann Holzmann, Michael Mazanek, Thomas Taus, Gustav Ammerer, Karl Mechtler · 2010 · Analytical Chemistry
  6. Perspectives of targeted mass spectrometry for protein biomarker verification
    Ruth Hüttenhain, Johan A. Malmström, Paola Picotti, Ruedi H. Aebersold · 2009 · Current Opinion in Chemical Biology
  7. Biomarkers of sepsis and their potential value in diagnosis, prognosis and treatment
    Mary K. Sandquist, Hector R. Wong · 2014 · Expert Review of Clinical Immunology
  8. Targeted and Untargeted Proteomics Approaches in Biomarker Development
    Constance A. Sobsey, Sahar Ibrahim, Vincent R. Richard, Vanessa Pinatto Gaspar, Georgia Mitsa, Vincent Lacasse, René Peiman Zahedi, Gerald Batist, Christoph H. Borchers · 2019 · PROTEOMICS
  9. Magnetic Colloidal Supraparticles: Design, Fabrication and Biomedical Applications
    Jia Guo, Wuli Yang, Changchun Wang · 2013 · Advanced Materials
  10. The oral microbiome in the pathophysiology of cardiovascular disease
    Andrea Tonelli, Evelyn Ngwa Lumngwena, Ntobeko Ntusi · 2023 · Nature Reviews Cardiology
  11. Implementation of proteomic biomarkers: making it work
    Harald Mischak, John P. A. Ioannidis, Àngel Argilés, Teresa K. Attwood, Erik Bongcam‐Rudloff, Mark Brönstrup, ARISTIDIS S. CHARONIS, George Panagiotis Chrousos, Christian Delles, Anna F. Dominiczak et al. · 2012 · European Journal of Clinical Investigation
  12. Challenging homeostasis to define biomarkers for nutrition related health
    van Ommen, Ben, Keijer, Jaap, Heil, Sandra G., Kaput, Jim · 2009 · Molecular Nutrition & Food Research
  13. The Bottleneck in the Cancer Biomarker Pipeline and Protein Quantification through Mass Spectrometry–Based Approaches: Current Strategies for Candidate Verification
    Shalini Makawita, Eleftherios P. Diamandis · 2009 · Clinical Chemistry
  14. Multi-level Proteomics Identifies CT45 as a Chemosensitivity Mediator and Immunotherapy Target in Ovarian Cancer
    Fabian Coscia, Ernst R. Lengyel, Jaikumar Duraiswamy, Bradley Ashcroft, Michal Bassani‐Sternberg, Michael Wierer, Alyssa Johnson, Kristen Wroblewski, ANTHONY G. MONTAG, S. Diane Yamada et al. · 2018 · Cell
  15. MS-Based Proteomics of Body Fluids: The End of the Beginning
    Jakob Maximilian Bader, Vincent Albrecht, Matthias Mann · 2023 · Molecular & Cellular Proteomics
  16. Biomarkers for Parkinson’s Disease: How Good Are They?
    Tianbai Li, Weidong Le · 2019 · Neuroscience Bulletin
  17. Gold Nanoparticle-Based Activatable Probe for Sensing Ultralow Levels of Prostate-Specific Antigen
    Dingbin Liu, Xinglu Huang, Zhantong Wang, Albert J. Jin, Xiaolian Sun, Lei Zhu, Fu Wang, Ying Ma, Gang Niu, Angela R. Hight Walker et al. · 2013 · ACS Nano
  18. Interlaboratory Study Characterizing a Yeast Performance Standard for Benchmarking LC-MS Platform Performance
    Amanda G. Paulovich, Dean D. Billheimer, Amy‐Joan L. Ham, Lorenzo Vega‐Montoto, Paul A. Rudnick, David L. Tabb, Pei Wang, Ronald K. Blackman, David M. Bunk, Helene L. Cardasis et al. · 2009 · Molecular & Cellular Proteomics
  19. Biomarkers for the lung cancer diagnosis and their advances in proteomics
    Hye-Jin Sung, Je‐Yoel Cho · 2008 · BMB Reports
  20. Development and evaluation of a multiplexed mass spectrometry based assay for measuring candidate peptide biomarkers in Alzheimer's Disease Neuroimaging Initiative (ADNI) CSF
    Spellman, Daniel S., Wildsmith, Kristin R., Honigberg, Lee A., Tuefferd, Marianne, Baker, David, Raghavan, Nandini, Nairn, Angus C., Croteau, Pascal, Schirm, Michael, Allard, Rene et al. · 2015 · PROTEOMICS – Clinical Applications
  21. Current Status and Advances in Quantitative Proteomic Mass Spectrometry
    Valerie C. Wasinger, Ming Zeng, Yunki Y. Yau · 2013 · International Journal of Proteomics
  22. Serum matrix metalloproteinase-9 (MMP-9) as a biomarker for monitoring disease progression in Duchenne muscular dystrophy (DMD)
    Vishna Devi Nadarajah, Maaike van Putten, Amina Chaouch, Penny Garrood, Volker W. Straub, Hanns Lochmüller, Hendrika B. Ginjaar, Annemieke M Aartsma-Rus, Gert‐Jan B. van Ommen, Johan T. den Dunnen et al. · 2011 · Neuromuscular Disorders
  23. Proteomics of human cerebrospinal fluid: Discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics
    Ann Cathrine Kroksveen, Jill Anette Opsahl, Thin Thin Aye, Rune Johan Ulvik, Frode S. Berven · 2010 · Journal of Proteomics
  24. Accurate Inclusion Mass Screening
    Jacob D. Jaffe, Hasmik Keshishian, Betty Chang, Theresa A. Addona, Michael A. Gillette, Steven A. Carr · 2008 · Molecular & Cellular Proteomics
  25. Integrating high-throughput technologies in the quest for effective biomarkers for ovarian cancer
    Vathany Kulasingam, Maria P. Pavlou, Eleftherios P. Diamandis · 2010 · Nature reviews. Cancer
  26. Lab-on-chip technology for chronic disease diagnosis
    Wu, Jiandong, Dong, Meili, Rigatto, Claudio, Liu, Yong, Lin, Francis · 2018 · npj Digital Medicine
  27. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.
    Farid Ahmed, Nancy C. Ahmed, Paul W. Vos, Chris Bonnerup, James N. Atkins, Michelle Casey, Gerard James Nuovo, Wade Naziri, John E. Wiley, H Mota et al. · 2013 · PubMed
  28. Heat Stabilization of the Tissue Proteome: A New Technology for Improved Proteomics
    Marcus Svensson, Mats Borén, Karl Sköld, Maria Fälth, Benita Sjögren, Malin Andersson, Per Svenningsson, Per E. Andrén · 2009 · Journal of Proteome Research
  29. A Critical Assessment of Feature Selection Methods for Biomarker Discovery in Clinical Proteomics
    Christin Christin, Huub C. J. Hoefsloot, Age K. Smilde, Berend Hoekman, Frank Suits, Rainer Bischoff, Peter L. Horvatovich · 2012 · Molecular & Cellular Proteomics
  30. Top-down proteomics
    Roberts, David S., Loo, Joseph A., Tsybin, Yury O., Liu, Xiaowen, Wu, Si, Chamot-Rooke, Julia, Agar, Jeffrey N., Paša-Tolić, Ljiljana, Smith, Lloyd M., Ge, Ying · 2024 · Nature Reviews Methods Primers
  31. MicroRNAs and prostate cancer
    Valeria Coppola, Ruggero D. Maria, Désirée Bonci · 2009 · Endocrine Related Cancer
  32. The Long Journey of Cancer Biomarkers from the Bench to the Clinic
    Maria P. Pavlou, Eleftherios P. Diamandis, Ivan M. Blasutig · 2012 · Clinical Chemistry
  33. Molecular Elucidation of Disease Biomarkers at the Interface of Chemistry and Biology
    Liqin Zhang, Shuo Wan, Ying Yan Jiang, Yanyue Wang, Ting Fu, Qiaoling Liu, Zhijuan Cao, Liping Qiu, Weihong Tan · 2017 · Journal of the American Chemical Society
  34. Microarray methods for protein biomarker detection
    Hye Jin Lee, Alastair W. Wark, Robert M. Corn · 2008 · The Analyst
  35. Diagnosis and Monitoring of Abdominal Aortic Aneurysm: Current Status and Future Prospects
    Joseph Vaughan Moxon, Adam Parr, Theophilus I. Emeto, Philip J. Walker, Paul E Norman, Jonathan Golledge · 2010 · Current Problems in Cardiology
  36. Microfluidic platforms for biomarker analysis
    Sofia Nahavandi, Sara Baratchi, Rebecca Soffe, Shi‐Yang Tang, Saeid Nahavandi, Arnan Mitchell, Khashayar Khoshmanesh · 2014 · Lab on a Chip
  37. LIMPIC: a computational method for the separation of protein MALDI-TOF-MS signals from noise
    Dante Mantini, Francesca Petrucci, Damiana Pieragostino, Piero Del Boccio, Marta Di Nicola, Carmine Di Ilio, Giorgio Federici, Paolo Sacchetta, Silvia Comani, Andrea Urbani · 2007 · BMC Bioinformatics
  38. Label-Free Detection of Post-translational Modifications with a Nanopore
    Laura Restrepo-Pérez, Chun Heung Wong, Giovanni Maglia, Cees Dekker, Chirlmin Joo · 2019 · Nano Letters
  39. Protein Quantitation through Targeted Mass Spectrometry: The Way Out of Biomarker Purgatory?
    Steven A. Carr, Leigh Anderson · 2008 · Clinical Chemistry
  40. Biomarker discovery in mass spectrometry‐based urinary proteomics
    Samuel Thomas, Ling Hao, William A. Ricke, Lingjun Li · 2015 · PROTEOMICS - CLINICAL APPLICATIONS
  41. Single-Step Nanoplasmonic VEGF165 Aptasensor for Early Cancer Diagnosis
    Hansang Cho, Erh-Chia Yeh, Raghu Sinha, Ted A. Laurence, Jane P. Bearinger, Luke P. Lee · 2012 · ACS Nano
  42. Clinical proteomic biomarkers: relevant issues on study design & technical considerations in biomarker development
    Maria Frantzi, Akshay V. Bhat, Agnieszka Latosińska · 2014 · Clinical and Translational Medicine
  43. Deep undepleted human serum proteome profiling toward biomarker discovery for Alzheimer’s disease
    Dey, Kaushik Kumar, Wang, Hong, Niu, Mingming, Bai, Bing, Wang, Xusheng, Li, Yuxin, Cho, Ji-Hoon, Tan, Haiyan, Mishra, Ashutosh, High, Anthony A. et al. · 2019 · Clinical Proteomics
  44. Evaluation of Large Scale Quantitative Proteomic Assay Development Using Peptide Affinity-based Mass Spectrometry
    Jeffrey R. Whiteaker, Lei Zhao, Susan E. Abbatiello, Michael W. Burgess, Eric W. Kuhn, Chenwei Lin, Matthew E. Pope, Morteza Razavi, N. Leigh Anderson, Terry W. Pearson et al. · 2011 · Molecular & Cellular Proteomics
  45. Development of biomarkers to chart all Alzheimer's disease stages: The royal road to cutting the therapeutic Gordian Knot
    Harald Juergen Hampel, Simone Lista, Zaven S. Khachaturian · 2012 · Alzheimer s & Dementia
  46. Advancing Urinary Protein Biomarker Discovery by Data-Independent Acquisition on a Quadrupole-Orbitrap Mass Spectrometer
    Jan Muntel, Yue Xuan, Sebastian T. Berger, Lukas Reiter, Richard G. Bachur, Alex Kentsis, Hanno Steen · 2015 · Journal of Proteome Research
  47. Quantitative proteomic profiling of cerebrospinal fluid to identify candidate biomarkers for Alzheimer’s disease
    Sathe, Gajanan, Na, Chan Hyun, Renuse, Santosh, Madugundu, Anil K., Albert, Marilyn, Moghekar, Abhay, Pandey, Akhilesh · 2019 · PROTEOMICS – Clinical Applications
  48. Sequential Protein and Peptide Immunoaffinity Capture for Mass Spectrometry-Based Quantification of Total Human β-Nerve Growth Factor
    Hendrik Neubert, David Muirhead, Musarat Kabir, Chris Grace, Adriaan Cleton, Rosalin Arends · 2012 · Analytical Chemistry
  49. Blood and plasma-based proteomic biomarker research in Alzheimer's disease
    Simone Lista, Frank Faltraco, David Prvulovic, Harald Juergen Hampel · 2012 · Progress in Neurobiology
  50. Cancer Biomarkers Discovery and Validation: State of the Art, Problems and Future Perspectives
    Alvaro Mordente, Elisabetta Meucci, Giuseppe Ettore Martorana, Andrea Silvestrini · 2015 · Advances in experimental medicine and biology
  51. A Strategy to Combine Sample Multiplexing with Targeted Proteomics Assays for High-Throughput Protein Signature Characterization
    Brian K. Erickson, Christopher M. Rose, Craig R. Braun, Alison R. Erickson, Jeffrey Knott, Graeme C. McAlister, Martin Wühr, João A. Paulo, Robert A. Everley, Steven P. Gygi · 2017 · Molecular Cell
  52. Measurement by a Novel LC-MS/MS Methodology Reveals Similar Serum Concentrations of Vitamin D–Binding Protein in Blacks and Whites
    Henderson, Clark M, Lutsey, Pamela L, Misialek, Jeffrey R, Laha, Thomas J, Selvin, Elizabeth, Eckfeldt, John H, Hoofnagle, Andrew N · 2016 · Clinical Chemistry
  53. Silicon nanowires as field-effect transducers for biosensor development: A review
    M. Omair Noor, Ulrich J. Krull · 2014 · Analytica Chimica Acta
  54. Mass spectrometric protein maps for biomarker discovery and clinical research
    Yansheng Liu, Ruth Hüttenhain, Ben C. Collins, Ruedi H. Aebersold · 2013 · Expert Review of Molecular Diagnostics
  55. Statistical Design for Biospecimen Cohort Size in Proteomics-based Biomarker Discovery and Verification Studies
    Steven J. Skates, Michael A. Gillette, Joshua LaBaer, Steven A. Carr, Leigh Anderson, Daniel C. Liebler, David F. Ransohoff, Nader Rifai, Marina Kondratovich, Živana Težak et al. · 2013 · Journal of Proteome Research
  56. Targeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer
    Yunee Kim, Jouhyun Jeon, Salvador Mejia, Cindy Q. Yao, Vladimir Ignatchenko, Julius O. Nyalwidhe, Anthony O. Gramolini, Raymond S. Lance, Dean A. Troyer, Richard R. Drake et al. · 2016 · Nature Communications
  57. Meta-proteomics for the discovery of protein biomarkers of beef tenderness: An overview of integrated studies
    Brigitte B. Picard, Mohammed Gagaoua · 2019 · Food Research International
  58. Coffee Ring Aptasensor for Rapid Protein Detection
    Jessica T. Wen, Chih‐Ming Ho, Peter B. Lillehoj · 2013 · Langmuir
  59. Addressing the Challenge of Defining Valid Proteomic Biomarkers and Classifiers
    Mohammed Dakna, Keith J. Harris, Alexandros Kalousis, Sébastien Carpentier, Walter Kölch, Joost Peter Schanstra, Marion Haubitz, Antonia Vlahou, Harald Mischak, Mark Girolami · 2010 · BMC Bioinformatics
  60. Organic Electrochemical Transistors for Biomarker Detections
    Hong Liu, Jiajun Song, Zeyu Zhao, Sanqing Zhao, Zhiyuan Tian, Feng Yan · 2024 · Advanced Science
  61. Extensive Peptide Fractionation and <i>y</i><sub>1</sub> Ion-Based Interference Detection Method for Enabling Accurate Quantification by Isobaric Labeling and Mass Spectrometry
    Niu, Mingming, Cho, Ji-Hoon, Kodali, Kiran, Pagala, Vishwajeeth, High, Anthony A., Wang, Hong, Wu, Zhiping, Li, Yuxin, Bi, Wenjian, Zhang, Hui et al. · 2017 · Analytical Chemistry
  62. Improving the Limit of Detection of Nanoscale Sensors by Directed Binding to High-Sensitivity Areas
    Laurent Feuz, Peter Jönsson, Magnus P. Jonsson, Fredrik Höök · 2010 · ACS Nano
  63. Blood autoantibody and cytokine profiles predict response to anti-tumor necrosis factor therapy in rheumatoid arthritis
    Wolfgang Hueber, Beren H. Tomooka, Franak Batliwalla, Wentian Li, Paul A. Monach, Robert John Tibshirani, Ronald van Vollenhoven, Jon Lampa, Kazuyoshi Saito, Yoshiya Tanaka et al. · 2009 · Arthritis Research & Therapy
  64. Statistical characterization of multiple-reaction monitoring mass spectrometry (MRM-MS) assays for quantitative proteomics
    D.R. Mani, Susan E. Abbatiello, Steven A. Carr · 2012 · BMC Bioinformatics
  65. From Lost in Translation to Paradise Found: Enabling Protein Biomarker Method Transfer by Mass Spectrometry
    Russell P. Grant, Andrew N. Hoofnagle · 2014 · Clinical Chemistry
  66. Distinct Cerebrospinal Fluid Proteomes Differentiate Post-Treatment Lyme Disease from Chronic Fatigue Syndrome
    Steven E. Schutzer, Thomas E. Angel, Tao Liu, Athena Schepmoes, Therese RW Clauss, Joshua Adkins, David Camp, Bart K. Holland, Jonas Bergquist, Patricia Katherine Coyle et al. · 2011 · PLoS ONE
  67. Neurodegeneration and Alzheimer's disease (AD). What Can Proteomics Tell Us About the Alzheimer's Brain?
    Guillermo Moya‐Alvarado, Noga Gershoni‐Emek, Eran Perlson, Francisca C. Bronfman · 2016 · Molecular & Cellular Proteomics
  68. Advances in nanowire bioelectronics
    Wei Min Zhou, Xiaochuan Dai, Charles M. Lieber · 2016 · Reports on Progress in Physics
  69. The Case for Proteomics and Phospho‐Proteomics in Personalized Cancer Medicine
    Sophia Doll, Florian Gnad, Matthias Mann · 2019 · PROTEOMICS - CLINICAL APPLICATIONS
  70. Design of Surface Modifications for Nanoscale Sensor Applications
    Erik Reimhult, Fredrik Höök · 2015 · Sensors
  71. A new panel of pancreatic cancer biomarkers discovered using a mass spectrometry-based pipeline
    Xiaohui Liu, Weimin Zheng, Wansheng Wang, Huali Shen, Linxiao Liu, Wenhui Lou, Xiaolin Wang, Pengyuan Yang · 2017 · British Journal of Cancer
  72. Expression of MicroRNAs in the Urinary Sediment of Patients with IgA Nephropathy
    Gang Wang, Bonnie Ching‐Ha Kwan, Fernand Mac–Moune Lai, Kai Ming Chow, Philip Kam‐Tao Li, Cheuk‐Chun Szeto · 2010 · Disease Markers
  73. Global and targeted quantitative proteomics for biomarker discovery
    Timothy D. Veenstra · 2006 · Journal of Chromatography B
  74. Integrated Proteomic Profiling of Cell Line Conditioned Media and Pancreatic Juice for the Identification of Pancreatic Cancer Biomarkers
    Shalini Makawita, Christopher R. Smith, Ihor Batruch, Yingye Zheng, Felix Rückert, Robert Grützmann, Christian P. Pilarsky, Steve Gallinger, Eleftherios P. Diamandis · 2011 · Molecular & Cellular Proteomics
  75. The Challenges of Developing Biosensors for Clinical Assessment: A Review
    Briliant Adhi Prabowo, Patrícia D. Cabral, P. P. Freitas, Elisabete Fernandes · 2021 · Chemosensors
  76. Development and validation of a novel protein extraction methodology for quantitation of protein expression in formalin‐fixed paraffin‐embedded tissues using western blotting
    Niroshini J. Nirmalan, Patricia Harnden, Peter John Selby, Rosamonde Elizabeth Banks · 2009 · The Journal of Pathology
  77. Biomarkers: hopes and challenges in the path from discovery to clinical practice
    Nikolaos Georgios Frangogiannis · 2012 · Translational research
  78. Recent advances in simultaneous electrochemical multi-analyte sensing platforms
    Parvin Samadi Pakchin, Sattar Akbari Nakhjavani, Reza Saber, Hossein Ghanbari, Yadollah Omidi · 2017 · TrAC Trends in Analytical Chemistry
  79. Tumor Interstitial Fluid Formation, Characterization, and Clinical Implications
    Marek Wagner, Helge Wiig · 2015 · Frontiers in Oncology
  80. The cancer secretome, current status and opportunities in the lung, breast and colorectal cancer context
    Tieneke B.M. Schaaij‐Visser, Meike de Wit, Siu W. Lam, Connie R. Jiménez · 2013 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
  81. Focused Differential Glycan Analysis with the Platform Antibody-assisted Lectin Profiling for Glycan-related Biomarker Verification
    Atsushi Kuno, Yukinari Kato, Atsushi Matsuda, Mika Kato Kaneko, Hiromi Ito, Koh Amano, Yasunori Chiba, Hisashi Narimatsu, Jun Hirabayashi · 2008 · Molecular & Cellular Proteomics
  82. Methods for Peptide and Protein Quantitation by Liquid Chromatography-Multiple Reaction Monitoring Mass Spectrometry
    Haixia Zhang, Qinfeng Liu, Lisa J. Zimmerman, Amy‐Joan L. Ham, Robbert J.C. Slebos, Jamshedur S. M. Rahman, Takefume Kikuchi, Pierre P. Massion, David Paul Carbone, Dean D. Billheimer et al. · 2011 · Molecular & Cellular Proteomics
  83. Biomarker Discovery in Low-Grade Breast Cancer Using Isobaric Stable Isotope Tags and Two-Dimensional Liquid Chromatography-Tandem Mass Spectrometry (iTRAQ-2DLC-MS/MS) Based Quantitative Proteomic Analysis
    Pavel Bouchal, Theodoros I. Roumeliotis, Roman Hrstka, Rudolf Nenutil, Bořivoj Vojtěšek, Spiros D. Garbis · 2008 · Journal of Proteome Research
  84. Surface-Enhanced Raman Spectroscopy-Based, Homogeneous, Multiplexed Immunoassay with Antibody-Fragments-Decorated Gold Nanoparticles
    Yu Wang, Li‐Juan Tang, Jian‐Hui Jiang · 2013 · Analytical Chemistry
  85. Protein Biomarker Quantification by Immunoaffinity Liquid Chromatography–Tandem Mass Spectrometry: Current State and Future Vision
    Neubert, Hendrik, Shuford, Christopher M, Olah, Timothy V, Garofolo, Fabio, Schultz, Gary A, Jones, Barry R, Amaravadi, Lakshmi, Laterza, Omar F, Xu, Keyang, Ackermann, Bradley L · 2020 · Clinical Chemistry
  86. From differentiating metabolites to biomarkers
    Albert Koulman, Geoffrey A. Lane, Scott James Harrison, Dietrich A. Volmer · 2009 · Analytical and Bioanalytical Chemistry
  87. Improved Electrospray Ionization Efficiency Compensates for Diminished Chromatographic Resolution and Enables Proteomics Analysis of Tyrosine Signaling in Embryonic Stem Cells
    Scott B. Ficarro, Yi Zhang, Yu Lu, Ahmadali R. Moghimi, Manor Askenazi, Elzbieta Hyatt, Eric D. Smith, Leah F. Boyer, Thorsten M. Schlaeger, Chance John Luckey et al. · 2009 · Analytical Chemistry
  88. Protein Microarrays for Personalized Medicine
    Xiaobo Yu, Nicole Schneiderhan‐Marra, Thomas O Joos · 2010 · Clinical Chemistry
  89. Proteomics of colorectal cancer: Overview of discovery studies and identification of commonly identified cancer-associated proteins and candidate CRC serum markers
    Connie R. Jiménez, Jaco C. Knol, Gerrit A. Meijer, Remond J.A. Fijneman · 2010 · Journal of Proteomics
  90. Mass spectrometry-based proteomics for systems biology
    Eduard Sabidó, Nathalie Selevsek, Ruedi H. Aebersold · 2011 · Current Opinion in Biotechnology
  91. Disposable Electrochemical Aptasensor Array by Using in Situ DNA Hybridization Inducing Silver Nanoparticles Aggregate for Signal Amplification
    Wei Song, Hui Li, Hua Liang, Weibing Qiang, Danke Xu · 2014 · Analytical Chemistry
  92. Targeted Proteomics Guided by Label-free Quantitative Proteome Analysis in Saliva Reveal Transition Signatures from Health to Periodontal Disease
    Nagihan Bostancı, Nathalie Selevsek, Witold Wolski, Jonas Grossmann, Kai Bao, Åsa Wåhlander, Christian Trachsel, Ralph Schlapbach, Veli Özgen Öztürk, Beral Afacan et al. · 2018 · Molecular & Cellular Proteomics
  93. Oncoproteomics: current trends and future perspectives
    William Chi Shing Cho, Christopher H.K. Cheng · 2007 · Expert Review of Proteomics
  94. Spectral Index for Assessment of Differential Protein Expression in Shotgun Proteomics
    Xiaoyun Fu, Sina A. Gharib, Pattie S. Green, Moira L. Aitken, David A. Frazer, David R. Park, Tomáš Vaisar, Jay W. Heinecke · 2008 · Journal of Proteome Research
  95. Targeted mass spectrometry approaches for protein biomarker verification
    Zhaojing Meng, Timothy D. Veenstra · 2011 · Journal of Proteomics
  96. Up‐regulated Proteins in the Fluid Bathing the Tumour Cell Microenvironment as Potential Serological Markers for Early Detection of Cancer of the Breast
    Pavel Gromov, Irina Gromova, Jakob Bunkenborg, Teresa Cabezón, José M.A. Moreira, Vera Timmermans Wielenga, Peter Roepstorff, Fritz E Rank, Julio E. Celis · 2009 · Molecular Oncology
  97. MRMaid, the Web-based Tool for Designing Multiple Reaction Monitoring (MRM) Transitions
    Jennifer A. Mead, Luca Bianco, Vanessa Ottone, Chris Barton, Richard G. Kay, Kathryn Susan Lilley, Nicholas J. Bond, Conrad Bessant · 2008 · Molecular & Cellular Proteomics
  98. Absolute quantification of microbial proteomes at different states by directed mass spectrometry
    Alexander Schmidt, Martin Beck, Johan A. Malmström, Henry Lam, Manfred Claassen, David S Campbell, Ruedi H. Aebersold · 2011 · Molecular Systems Biology
  99. Proteomics Research in Cardiovascular Medicine and Biomarker Discovery
    Maggie P. Y. Lam, Peipei Ping, Elizabeth Murphy · 2016 · Journal of the American College of Cardiology
  100. Recent advances on nanomaterial based electrochemical and optical aptasensors for detection of cancer biomarkers
    Reza Eivazzadeh‐Keihan, Paria Pashazadeh‐Panahi, Behzad Baradaran, Ali Reza Maleki, Maryam Hejazi, Ahad Mokhtarzadeh, Miguel de la Guárdia · 2018 · TrAC Trends in Analytical Chemistry